Regular patient/clinician interaction can help increase follow-up cancer screening

August 17, 2012

The line “talk to your doctor,” which appears in so many medical-related advertisements, is apparently right. An analysis of colorectal cancer (CRC) patients who maintained regular contact with their clinicians (doctors, nurses, specialists) indicates those patients are more likely to follow recommendations for detecting cancer recurrence than patients who do not. In fact, researchers found CRC patients were more than twice as likely to adhere to medical follow up procedures if they had regular patient clinician information engagement (PCIE).

The study was conducted by a team of researchers from the Center of Excellence in Cancer Communication Research (CECCR) at the University of Pennsylvania’s Annenberg School for Communication. The research team—doctoral student Andy S.L. Tan; Mihaela Moldovan-Johnson, Ph.D.; doctoral student Sarah Parvanta; Stacy W. Gray, MD; Katrina Armstrong, MD; and Robert C. Hornik, Ph.D.—followed over 300 CRC since 2005. The results of their work currently appear in the journal The Oncologist, the official journal of the Society for Translational Oncology. The article title is “Patient-Clinician Information Engagement Improves Adherence to Colorectal Cancer Surveillance after Curative Treatment: Results from a Longitudinal Study.”

The patients in the study—roughly half male, half female; mostly white (88.5 percent); a mean age of 68; and most (72.5%) indicating concern about cancer recurrence—responded to surveys over the three-year span of the study. All reported whether they had received specific follow up screening tests—two or more office visits, two or more serum carcinoembryonic antigen (CEA) tests, and one colonoscopy. The study tracked how often these procedures were received in comparison to the amount of interaction patients had with their clinicians.

While only 41 percent reported receiving all three surveillance procedures, the researchers did note that patients who had consistent PCIE were 2.8 times more likely to adhere to recommended follow up tests.

In the article the research team acknowledges that several socio-demographic and clinical factors affecting whether or not someone follows advice cannot be modified. These include the patients’ age, income level, race, and severity (stage) of the cancer. However, they note that understanding the impact and effects of PCIE can help health professionals develop pilot interventions to improve adherence through patient active engagement with their clinicians on cancer-related information.

“We recommend that prospective studies be considered to determine if pilot programs encouraging active patient engagement with clinicians about -related information would be beneficial in terms of increasing the proportion of patients receiving post-treatment surveillance testing, and ultimately in improving patient outcomes and survival,” the researchers write in their conclusion.

Explore further: Patient navigators appear to improve colorectal cancer screening rate in ethnically diverse patients

More information: The Oncologist August 2012 doi: 10.1634/theoncologist.2012-0173

Related Stories

Recommended for you

Dogs detect breast cancer from bandage: researchers

March 24, 2017

Dogs can sniff out cancer from a piece of cloth which had touched the breast of a woman with a tumour, researchers said Friday, announcing the results of an unusual, but promising, diagnostic trial.

'Jumonji' protein key to Ewing's sarcoma rampage

March 24, 2017

By the time Ewing's Sarcoma is diagnosed, primarily in teens and young adults, it has often spread from its primary site to other parts of the body, making it difficult to treat. A University of Colorado Cancer Center study ...

In a sample of blood, researchers probe for cancer clues

March 24, 2017

One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study, led by bioengineers at UC Berkeley, has taken an important step in that direction by measuring ...

Researchers gain insight into breast cancer drug resistance

March 24, 2017

Breast cancer's ability to develop resistance to treatment has frustrated researchers and physicians and has thwarted even the latest and greatest targeted therapies. For example, after researchers identified a disease pathway ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.